China Life Insurance (Overseas) Company Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4046
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

China Life Insurance (Overseas) Company Limited – Strategy, SWOT and Corporate Finance Report
Summary

China Life Insurance (Overseas) Company Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

China Life Insurance (Overseas) Company Ltd (China Life Overseas),asubsidiary of China Life Insurance (Group) Company, is a life insurance company. It offers a range of life insurance products to individuals and group customers. Its individual life insurance products include whole life insurance plans, healthy life insurance plans, treasure insurance plans, education savings plans, savings insurance plans, lifelong attention insurance plans and retirement plans. The company’s group insurance products include term life insurance, accidental death and disability insurance, and hospitalization and medical protection plans. China Life Overseas has its presence in Hong Kong and Macau. The company is headquartered in Wan Chai, Hong Kong.

The company reported total premium income of about HKD40 billion in FY2015.

Scope

- Detailed information on China Life Insurance (Overseas) Company Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting China Life Insurance (Overseas) Company Limited in the form of a SWOT analysis
- An in-depth view of the business model of China Life Insurance (Overseas) Company Limited including a breakdown and examination of key business segments
- Intelligence on China Life Insurance (Overseas) Company Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about China Life Insurance (Overseas) Company Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of China Life Insurance (Overseas) Company Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess China Life Insurance (Overseas) Company Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on China Life Insurance (Overseas) Company Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
China Life Insurance (Overseas) Company Limited: Company Overview 8
China Life Insurance (Overseas) Company Limited: Overview and Key Facts 8
China Life Insurance (Overseas) Company Limited: Overview 8
China Life Insurance (Overseas) Company Limited: Key Facts 8
China Life Insurance (Overseas) Company Limited: Key Employees 9
China Life Insurance (Overseas) Company Limited: Key Employee Biographies 10
China Life Insurance (Overseas) Company Limited: Major Products and Services 11
China Life Insurance (Overseas) Company Limited: Company History 12
China Life Insurance (Overseas) Company Limited: Management Statement 14
China Life Insurance (Overseas) Company Limited: Locations and Subsidiaries 15
China Life Insurance (Overseas) Company Limited: Key Competitors 16
China Life Insurance (Overseas) Company Limited: Company Analysis 17
China Life Insurance (Overseas) Company Limited: Business Description 17
China Life Insurance (Overseas) Company Limited: SWOT Analysis 18
China Life Insurance (Overseas) Company Limited: SWOT Overview 18
China Life Insurance (Overseas) Company Limited: Strengths 18
China Life Insurance (Overseas) Company Limited: Weaknesses 19
China Life Insurance (Overseas) Company Limited: Opportunities 19
China Life Insurance (Overseas) Company Limited: Threats 19
China Life Insurance (Overseas) Company Limited: Corporate Financial Deals Activity 21
China Life Insurance (Overseas) Company Limited: Financial Deals Overview 21
China Life Insurance (Overseas) Company Limited: Targets and Partners 22
China Life Insurance (Overseas) Company Limited: Top Deals 2014 – 2018YTD* 23
China Life Insurance (Overseas) Company Limited: Advisors 24
China Life Insurance (Overseas) Company Limited: Top Financial Advisors 24
China Life Insurance (Overseas) Company Limited: Mergers and Acquisitions 25
China Life Insurance (Overseas) Company Limited: Capital Raising 26
China Life Insurance (Overseas) Company Limited: Recent Developments 27
China Life Insurance (Overseas) Company Limited: News and Events Summary 27
China Life Insurance (Overseas) Company Limited: Strategy and Operations 27
Appendix 28
Contact Us 28
Methodology 28
About MarketLine 29

List of Tables
Table 1: China Life Insurance (Overseas) Company Limited: Key Facts
Table 2: China Life Insurance (Overseas) Company Limited: Key Employees
Table 3: China Life Insurance (Overseas) Company Limited: Locations and Subsidiaries
Table 4: China Life Insurance (Overseas) Company Limited: Key Competitors
Table 5: China Life Insurance (Overseas) Company Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: China Life Insurance (Overseas) Company Limited: Targets and Partners
Table 7: China Life Insurance (Overseas) Company Limited: Top Deals 2014 - 2018YTD*
Table 8: China Life Insurance (Overseas) Company Limited: Financial Advisor Ranking by Value (US$m)
Table 9: China Life Insurance (Overseas) Company Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: China Life Insurance (Overseas) Company Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 11: China Life Insurance (Overseas) Company Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 12: China Life Insurance (Overseas) Company Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 13: China Life Insurance (Overseas) Company Limited: News and Events Summary
Table 14: China Life Insurance (Overseas) Company Limited: Strategy and Operations

List of Figures
Figure 1: China Life Insurance (Overseas) Company Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: China Life Insurance (Overseas) Company Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: China Life Insurance (Overseas) Company Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: China Life Insurance (Overseas) Company Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 5: China Life Insurance (Overseas) Company Limited: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[China Life Insurance (Overseas) Company Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Termas De Puyehue S.A.:企業の戦略・SWOT・財務分析
    Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report Summary Termas De Puyehue S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報
    Summary Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerativ …
  • Intel Corporation:企業のM&A・事業提携・投資動向
    Intel Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intel Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • The Rank Group Plc (RNK):企業の財務・戦略的SWOT分析
    The Rank Group Plc (RNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CHS Inc (CHSCP):企業の財務・戦略的SWOT分析
    CHS Inc (CHSCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Tecomet Inc:医療機器:M&Aディール及び事業提携情報
    Summary Tecomet Inc (Tecomet) is a medical equipment company that manufactures and markets cases, implants and instruments. The company offers various implants which include acetabular cups, femoral heads, femoral stems, poly liners, femoral wraps, patellas, poly inserts, tibia trays, hooks, plates, …
  • Ossur hf (OSSR):企業の財務・戦略的SWOT分析
    Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • OBJ Ltd (OBJ)-医療機器分野:企業M&A・提携分析
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Vingroup Joint Stock Co:企業の戦略・SWOT・財務分析
    Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vingroup Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tactile Systems Technology Inc (TCMD):製品パイプライン分析
    Summary Tactile Systems Technology Inc (Tactile Medical) is a medical technology company that develops, manufactures and distributes medical devices for the treatment of chronic vascular diseases in a home setting. The company’s products are based on a unique, scalable platform. It offers products f …
  • UNIQA Bulgaria:企業の戦略・SWOT・財務情報
    UNIQA Bulgaria - Strategy, SWOT and Corporate Finance Report Summary UNIQA Bulgaria - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ebara Corp (6361):企業の財務・戦略的SWOT分析
    Ebara Corp (6361) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aura Light International AB:企業の戦略的SWOT分析
    Aura Light International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • ENCE Energia Y Celulosa SA (ENC):企業の財務・戦略的SWOT分析
    ENCE Energia Y Celulosa SA (ENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Li Ning Company Ltd (2331)
    Li Ning Company Ltd (2331) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Esperion Therapeutics Inc (ESPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Beam Suntory Inc.:企業の戦略・SWOT・財務分析
    Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report Summary Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PeriGen Inc:医療機器:M&Aディール及び事業提携情報
    Summary PeriGen Inc (PeriGen), formerly E&C Medical Intelligence Inc is a healthcare technology company that offers advanced obstetric decision-support systems. The company offers fetal monitoring systems which include tracings, patterns, curve and shoulder screen systems. Its decision-support softw …
  • Chiome Bioscience Inc (4583):製薬・医療:M&Aディール及び事業提携情報
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that provides research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating syst …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆